Free Trial
NASDAQ:APM

Aptorum Group (APM) Stock Price, News & Analysis

Aptorum Group logo
$0.97 -0.03 (-3.00%)
Closing price 03:53 PM Eastern
Extended Trading
$0.97 +0.00 (+0.41%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Aptorum Group Stock (NASDAQ:APM)

Key Stats

Today's Range
$0.94
$1.00
50-Day Range
$0.71
$1.16
52-Week Range
$0.46
$7.49
Volume
22,832 shs
Average Volume
610,426 shs
Market Capitalization
$5.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.

Aptorum Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

APM MarketRank™: 

Aptorum Group scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Aptorum Group.

  • Percentage of Shares Shorted

    0.52% of the float of Aptorum Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptorum Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptorum Group has recently decreased by 46.24%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Aptorum Group does not currently pay a dividend.

  • Dividend Growth

    Aptorum Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.52% of the float of Aptorum Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptorum Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptorum Group has recently decreased by 46.24%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Aptorum Group has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.74 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Aptorum Group this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for APM on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Aptorum Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aptorum Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.99% of the stock of Aptorum Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.80% of the stock of Aptorum Group is held by institutions.

  • Read more about Aptorum Group's insider trading history.
Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

APM Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Aptorum Group faces Nasdaq minimum bid price warning
Aptorum Group receives Nasdaq non-compliance notification
See More Headlines

APM Stock Analysis - Frequently Asked Questions

Aptorum Group's stock was trading at $2.80 at the beginning of 2025. Since then, APM stock has decreased by 65.2% and is now trading at $0.9740.
View the best growth stocks for 2025 here
.

Aptorum Group's stock reverse split on the morning of Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of APM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptorum Group investors own include Pfizer (PFE), Meta Platforms (META), Adobe (ADBE), Cisco Systems (CSCO), Walt Disney (DIS), Gilead Sciences (GILD) and Amgen (AMGN).

Company Calendar

Today
4/25/2025
Next Earnings (Estimated)
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APM
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$430,000.00
Price / Cash Flow
N/A
Book Value
$2.97 per share
Price / Book
0.33

Miscellaneous

Free Float
1,866,000
Market Cap
$5.03 million
Optionable
Not Optionable
Beta
-0.24
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:APM) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners